Fates intertwined

Nature Biotechnology

Volumn 24, Issue 3, 2006, Pages 252-254

  Cooper, Garth J S ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b Protemix Inc ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

BIOTECHNOLOGY; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; COMMERCIAL PHENOMENA; DRUG INDUSTRY; DRUG RESEARCH; FUNDING; GENOMICS; HEALTH CARE COST; LOWEST INCOME GROUP; MALARIA; MARKET; MOLECULE; NOTE; PHILOSOPHY; PRIORITY JOURNAL; PRODUCTIVITY; SCIENCE;

BIOMEDICAL RESEARCH; BIOTECHNOLOGY; DRUG INDUSTRY; ENTREPRENEURSHIP; PRIVATE SECTOR;

EID: 33644854014     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0306-252     Document Type: Note

References (16)

1. Fishman, M.C. & Porter, J.A. Nature 437, 491-493 (2005).
2. Couzin, J. Science 309, 728-730 (2005).
3. http://www.gatesfoundation.org/Global Health
4. Cordwell, S.J. Arch. Microbiol. 172, 269-279 (1999).
5. Wu, L.F. et al. Nat. Genet. 31, 255-265 (2002).
6. Chivian, E. Can. Med. Assoc. J. 164, 66-69 (2001).
7. Strong, K., Mathers, C., Leeder, S. & Beaglehole, R. Lancet 366, 1578-1582 (2005).
8. Martikainen, J., Kivi, I. & Linnosmaa, I. Health Policy (New York) 74, 235-246 (2005).
9. Chale, S.S., Swai, A.B., Mujinja, P.G. & McLarty, D.G. Br. Med. J. 304, 1215-1218 (1992).
10. Patz, J.A., Campbell-Lendrum, D., Holloway, T. & Foley, J.A. Nature 438, 310-317 (2005).
11. Drews, J. Nat. Biotechnol. 16 (Suppl.) 22-24 (1998).
12. Strausberg, R.L., Simpson, A.J., Old, L.J. & Riggins, G.J. Nature 429, 469-474 (2004).
13. Glaser, V. Nat. Biotechnol. 17, 634 (1999).
14. Smith, J.J., Travis, S.M., Greenberg, E.P. & Welsh, M.J. Cell 85, 229-236 (1996).
15. Singh, P.K. et al. Nature 407, 762-764 (2000).
16. Reichart, J.M. Nat. Rev. Drug Discov. 2, 695-702 (2003).